- Home
- PMCB vs EDUC Comparison
PMCB vs EDUC Comparison
Compare PMCB & EDUC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- EDUC
- Stock Information
- Founded
- PMCB 1996
- EDUC 1965
- Country
- PMCB United States
- EDUC United States
- Employees
- PMCB N/A
- EDUC N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- EDUC Consumer Specialties
- Sector
- PMCB Health Care
- EDUC Consumer Discretionary
- Exchange
- PMCB Nasdaq
- EDUC Nasdaq
- Market Cap
- PMCB 13.9M
- EDUC 15.3M
- IPO Year
- PMCB N/A
- EDUC N/A
- Fundamental
- Price
- PMCB $1.62
- EDUC $1.73
- Analyst Decision
- PMCB
- EDUC
- Analyst Count
- PMCB 0
- EDUC 0
- Target Price
- PMCB N/A
- EDUC N/A
- AVG Volume (30 Days)
- PMCB 13.7K
- EDUC 15.3K
- Earning Date
- PMCB 12-24-2024
- EDUC 01-13-2025
- Dividend Yield
- PMCB N/A
- EDUC N/A
- EPS Growth
- PMCB N/A
- EDUC N/A
- EPS
- PMCB 0.74
- EDUC N/A
- Revenue
- PMCB N/A
- EDUC $42,415,800.00
- Revenue This Year
- PMCB N/A
- EDUC N/A
- Revenue Next Year
- PMCB N/A
- EDUC N/A
- P/E Ratio
- PMCB $2.25
- EDUC N/A
- Revenue Growth
- PMCB N/A
- EDUC N/A
- 52 Week Low
- PMCB $1.39
- EDUC $0.87
- 52 Week High
- PMCB $2.58
- EDUC $2.95
- Technical
- Relative Strength Index (RSI)
- PMCB 45.07
- EDUC 29.98
- Support Level
- PMCB $1.61
- EDUC $1.59
- Resistance Level
- PMCB $1.81
- EDUC $1.94
- Average True Range (ATR)
- PMCB 0.11
- EDUC 0.13
- MACD
- PMCB 0.00
- EDUC -0.02
- Stochastic Oscillator
- PMCB 43.64
- EDUC 21.05
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About EDUC Educational Development Corporation
Educational Development Corp is the United States trade publisher of the line of educational children's books produced in the United Kingdom. Its business activity functions with two reportable segments: PaperPie and Publishing. The Publishing Division segment markets its products to retail accounts, which include books, school supplies, toy and gift stores and museums, through commissioned sales representatives, trade and specialty wholesalers and an internal telesales group.